Non-communicable disease

Respiratory Diseases Vaccines Markets, 2020-2025 by Infection, Type, Age Group, Geography and the Impact of Covid-19 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 19, 2021
General Health, Pharmaceutical, Health, Medicine, Medical specialties, Health, Virology, Medical terminology, Respiratory disease, Vaccines, Vaccine, Coronavirus disease, Chronic condition, Non-communicable disease

The "Global Respiratory Diseases Vaccines Market by Infection, Type, Age Group, Geography and the Impact of Covid-19 (2020-2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Respiratory Diseases Vaccines Market by Infection, Type, Age Group, Geography and the Impact of Covid-19 (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
  • The market is driven by factors such as the increasing prevalence of respiratory diseases, a growing number of vaccines under trial, etc.
  • Increasing R&D expenditure and the increasing availability of vaccines through various collaborations is creating opportunities for market growth.
  • Chronic respiratory diseases (CRDs) are diseases of the airways and other structures of the lung.

North America L-Carnosine Market 2020-2026: Focus on Autism, Diabetes, Skin Support, Cardiovascular Support, Joint Support - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 28, 2020
Chemicals, Plastics, Pharmaceutical, Health, Manufacturing, Branches of biology, Psychiatric diagnosis, Health, Clinical medicine, Pervasive developmental disorders, Carnosine, Dipeptides, Autism, Alzheimer's disease, Diabetes, Non-communicable disease, Vitamin D and neurology

Increasing incidence and prevalence of CVD, neurological disorders, and diabetes are some of the major factors contributing to the growth of the market.

Key Points: 
  • Increasing incidence and prevalence of CVD, neurological disorders, and diabetes are some of the major factors contributing to the growth of the market.
  • The North America L-carnosine market is segmented on the basis of application and geography.
  • Based on the application, the market is segmented into autism, diabetes support, skin support, CVD support, joint support, and others, which include digestion support, Parkinson's disease, and Alzheimer's disease.
  • In 2019, the skin support segment is projected to contribute a significant share to the global market.

Radiology Information Systems (RIS) Market | Increasing Prevalence of Chronic Diseases to Boost the Market Growth | Technavio

Retrieved on: 
Friday, October 9, 2020
Cardiology, Technology, Health, Radiology, Other Technology, Medical devices, Research, Hospitals, Networks, Science, Hardware, Articles, Medical terminology, Nutrition, Health, Chronic condition, Cardiovascular disease, Medicine, Obesity, Non-communicable disease

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • View the full release here: https://www.businesswire.com/news/home/20201009005182/en/
    Technavio has announced its latest market research report titled Global Radiology Information Systems Market 2020-2024 (Graphic: Business Wire)
    The prevalence of chronic diseases such as cardiovascular diseases (CVD), cancer, neurological diseases, and orthopedic diseases is increasing across the world.
  • The rising prevalence of chronic diseases can be attributed to the increasing rate of risk factors, such as diabetes, hypertension, smoking, and obesity.
  • To help clients improve their market position, this RIS market forecast report provides a detailed analysis of the market leaders.

In-Vitro Diagnostics (IVDs) Market to reach US$ 98 Billion by 2025, Globally |CAGR: 5.24%|UnivDatos Market Insights

Retrieved on: 
Friday, September 18, 2020
Global health, Non-communicable disease

According to the analysis, the market was valued at US$ 68.92 billion in 2018 and is predicted to reach US$ 98.18 billion by 2025.

Key Points: 
  • According to the analysis, the market was valued at US$ 68.92 billion in 2018 and is predicted to reach US$ 98.18 billion by 2025.
  • It was estimated by WHO that, the proportion of the burden of Noncommunicable diseases (NCDs) will reach 57% by 2020.
  • The rising geriatric population also leads to an increase in age-related disorders thereby influencing the market growth.
  • Reagents dominated the product segment of the global In-Vitro Diagnostics market with a 69% share in 2018.

In-Vitro Diagnostics (IVDs) Market to reach US$ 98 Billion by 2025, Globally |CAGR: 5.24%|UnivDatos Market Insights

Retrieved on: 
Friday, September 18, 2020
Global health, Non-communicable disease

According to the analysis, the market was valued at US$ 68.92 billion in 2018 and is predicted to reach US$ 98.18 billion by 2025.

Key Points: 
  • According to the analysis, the market was valued at US$ 68.92 billion in 2018 and is predicted to reach US$ 98.18 billion by 2025.
  • It was estimated by WHO that, the proportion of the burden of Noncommunicable diseases (NCDs) will reach 57% by 2020.
  • The rising geriatric population also leads to an increase in age-related disorders thereby influencing the market growth.
  • Reagents dominated the product segment of the global In-Vitro Diagnostics market with a 69% share in 2018.

A Cooperative Study Published in BMJ Reveals the Association Between Recommended Physical Activity and Health

Retrieved on: 
Tuesday, August 4, 2020
Articles, Health, Medical terminology, Medicine, Global health, Health in the United States, Physical Activity Guidelines for Americans, United States Department of Health and Human Services, Physical exercise, Non-communicable disease, Chronic condition, Physical inactivity

Previous studies showed that physical inactivity is a major risk factor for chronic non-communicable diseases worldwide.

Key Points: 
  • Previous studies showed that physical inactivity is a major risk factor for chronic non-communicable diseases worldwide.
  • Although physical inactivity has been estimated to be responsible for 9 percent of premature death and $53.8 billion in health costs, it is still a worldwide public health problem.
  • The 2018 physical activity guidelines for Americans recommend that adults should engage in at least 150 minutes of moderate-intensity aerobic physical activity (e.g.
  • People can choose the appropriate type of physical activity according to their physical condition.

Join ACC, Global Partners for Dedicated Week of Action on NCDs

Retrieved on: 
Wednesday, May 13, 2020
Articles, Health, Global health, Non-communicable disease, Pfizer, United Nations Interagency Task Force on the Prevention and Control of NCDs

As the COVID-19 pandemic continues, high-risk patientsparticularly those with pre-existing conditions like heart diseasemake the prevention and control of NCDs more important than ever.

Key Points: 
  • As the COVID-19 pandemic continues, high-risk patientsparticularly those with pre-existing conditions like heart diseasemake the prevention and control of NCDs more important than ever.
  • In an effort to raise awareness of the global public health impact of non-communicable diseases the American College of Cardiology (ACC), has partnered with the World Heart Federation (WHF), NCD Alliance (NCDA) and Pfizer Upjohn for a Week of Action starting May 18 dedicated to raising awareness around the burden of NCDs worldwide.
  • Join the conversation online using #NCDs and #NCDAcademy.
  • The Week of Action will celebrate the launch of the ACC's NCD Academy.

South Africa Infection Control Market Forecasts to 2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 7, 2020
Health, Infectious diseases, Global health, Non-communicable disease

The "South Africa Infection Control Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "South Africa Infection Control Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The South Africa infection control market is estimated to grow at a CAGR of 7.37% by the end of 2025.
  • The market in South Africa is projected to grow at a fast rate due to the prevalence of communicable and non-communicable diseases.
  • Additionally, the presence of major market players manufacturing innovative infection control products including sterilizers, disinfectants, and many more for consumption in the South African region are contributing to market growth over the next five years.

Improved Cost-effectiveness of Secondary Prevention of Kidney Disease by Targeting Higher Risk Populations

Retrieved on: 
Wednesday, March 11, 2020
RTT, Medicine, Anatomy, Kidney diseases, Health, Medical terminology, Organ failure, Chronic kidney disease, Chronic condition, Diabetes, Preventive healthcare, Non-communicable disease

BRUSSELS, March 11, 2020 /PRNewswire/ --One in three people in the general population (an estimated 850 million people) is at increased risk of chronic kidney disease (CKD).

Key Points: 
  • BRUSSELS, March 11, 2020 /PRNewswire/ --One in three people in the general population (an estimated 850 million people) is at increased risk of chronic kidney disease (CKD).
  • And although an estimated 10% of people worldwide have CKD, estimates suggest 9 in 10 of those are unaware of their condition.
  • Moreover, cost-effectiveness can be increased by adopting secondary prevention measures for higher risk populations such as those with diabetes mellitus and hypertension and those with rapid CKD progression.
  • Concretely, this means making populations aware of the risks through global communication campaigns and empowering patients through, for example, online learning platforms.

Insights on the $43+ Billion Gluten-Free Products Market to 2027 - High Cases of Misdiagnosis Helping to Drive the Product Demand

Retrieved on: 
Thursday, February 27, 2020
Articles, Health, Medicine, Medical terminology, Nutrition, Gluten, Chronic condition, Non-communicable disease, Wheat allergy, Disease

The global gluten-free products market size is projected to reach USD 43.65 billion by 2027, exhibiting a CAGR of 9.2% during the forecast period according to this report.

Key Points: 
  • The global gluten-free products market size is projected to reach USD 43.65 billion by 2027, exhibiting a CAGR of 9.2% during the forecast period according to this report.
  • The rising prevalence of lifestyle-related diseases has favored is driving the product demand.
  • Increasing instances of diseases, most notably chronic and non-communicable diseases leading to disability or death have bolstered the demand for gluten-free products.
  • High cases of misdiagnosis of the disease is likely to drive the product demand in the country.